Galmed Pharmaceuticals Ltd. (GLMD) Description, Stock price, News & Info

#ThinkSabio Latest News

$GLMD Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor